Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.verified

ENSC

Price:

$8.26

Market Cap:

$10.78M

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection agains...[Read more]

Industry

Biotechnology

IPO Date

2018-03-14

Stock Exchange

NASDAQ

Ticker

ENSC

The ROE as of December 2024 (TTM) for Ensysce Biosciences, Inc. (ENSC) is -268.39%

According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -268.39%. This represents a change of -401.83% compared to the average of 88.92% of the last 4 quarters.

Ensysce Biosciences, Inc. (ENSC) Historical ROE (quarterly & annually)

How has ENSC ROE performed in the past?

The mean historical ROE of Ensysce Biosciences, Inc. over the last ten years is 611.23%. The current -268.39% ROE has changed -143.91% with respect to the historical average. Over the past ten years (40 quarters), ENSC's ROE was at its highest in in the September 2021 quarter at 16.24%. The ROE was at its lowest in in the March 2023 quarter at -1096.56%.

Quarterly (TTM)
Annual

Average

611.23%

Median

14.57%

Minimum

-0.68%

Maximum

3.29%

Ensysce Biosciences, Inc. (ENSC) ROE by Quarter and Year

Discovering the peaks and valleys of Ensysce Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.16%

Maximum Annual ROE = 3.29%

Minimum Annual Increase = -216.58%

Minimum Annual ROE = -0.68%

Quarterly (TTM)
Annual
YearROEChange
20233.29%430.67%
2022619.45%73.39%
2021357.26%2.35%
202014.57%1.74%
20190.79%-216.58%
2018-0.68%4.16%

Ensysce Biosciences, Inc. (ENSC) Average ROE

How has ENSC ROE performed in the past?

The current ROE of Ensysce Biosciences, Inc. (ENSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.42%

5-year avg

855.86%

10-year avg

611.23%

Ensysce Biosciences, Inc. (ENSC) ROE vs. Peers

How is ENSC’s ROE compared to its peers?

Ensysce Biosciences, Inc.’s ROE is greater than Zura Bio Limited (-39.61%), greater than Phio Pharmaceuticals Corp. (-134.57%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than 180 Life Sciences Corp. (-559.06%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than Virax Biolabs Group Limited (-115.10%), greater than Blue Water Vaccines, Inc. (-126.11%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Hillstream BioPharma, Inc. (-172.28%), less than Kiora Pharmaceuticals, Inc. (21.31%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Allarity Therapeutics, Inc. (-328.22%), less than Kiromic BioPharma, Inc. (327.18%), greater than Biodexa Pharmaceuticals Plc (-101.74%), greater than PaxMedica, Inc. Common Stock (-3167.06%),

Build a custom stock screener for Ensysce Biosciences, Inc. (ENSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ensysce Biosciences, Inc. (ENSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Ensysce Biosciences, Inc.'s ROE?

How is the ROE calculated for Ensysce Biosciences, Inc. (ENSC)?

What is the highest ROE for Ensysce Biosciences, Inc. (ENSC)?

What is the 3-year average ROE for Ensysce Biosciences, Inc. (ENSC)?

What is the 5-year average ROE for Ensysce Biosciences, Inc. (ENSC)?

How does the current ROE for Ensysce Biosciences, Inc. (ENSC) compare to its historical average?